BIM
PDSB icon

BlackRock Investment Management’s PDS Biotechnology PDSB Stock Holding History

BlackRock Investment Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$810K Sell
3,241
-8
-0.2% -$1.82K ﹤0.01% 2815
2016
Q3 		$676K Sell
3,249
-4
-0.1% -$793 ﹤0.01% 2889
2016
Q2 		$658K Buy
3,253
+1,723
+113% +$305K ﹤0.01% 2910
2016
Q1 		$280K Buy
1,530
+67
+5% +$12K ﹤0.01% 3092
2015
Q4 		$366K Buy
+1,463
New +$472K ﹤0.01% 3108

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Investment Management's PDSB Position: Q4 2016 in Review

BlackRock Investment Management reduced its PDS Biotechnology (PDSB) stake by 0.25% in Q4 2016, selling an estimated $1.82K and leaving 3,241 shares worth $810K. The position accounts for ﹤0.01% of the portfolio, ranked #2815.

BlackRock Investment Management first reported a position in PDSB in Q4 2015 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2016.

  • BlackRock Investment Management held 3,241 shares of PDS Biotechnology worth $810K as of Q4 2016.
  • BlackRock Investment Management sold 8 PDS Biotechnology shares in Q4 2016, an estimated $1.82K.
  • PDS Biotechnology made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2815 holding.
  • BlackRock Investment Management first reported a position in PDS Biotechnology in Q4 2015 and has held it in 5 quarters since.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.